e-learning
resources
European Respiratory Review
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diagnosing alpha 1-antitrypsin deficiency: how to improve the current algorithm
McElvaney Noel G.
Source:
Eur Respir Rev 2015; 24: 52-57
Journal Issue:
March
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
McElvaney Noel G.. Diagnosing alpha 1-antitrypsin deficiency: how to improve the current algorithm. Eur Respir Rev 2015; 24: 52-57
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
COVID-19 infection in Severe Alpha 1-antitrypsin deficiency: looking for a rationale
Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19
Year: 2021
Targeted screening programmes in COPD: how to identify individuals with alpha 1-antitrypsin deficiency
Source: Eur Respir Rev 2015; 24: 40-45
Year: 2015
Clinical features of alpha one antitrypsin deficiency in COPD
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Phase I safety investigation of an aerosolized, recombinant alpha 1-antitrypsin in subjects with alpha 1-antitrypsin deficiency
Source: Eur Respir J 2004; 24: Suppl. 48, 228s
Year: 2004
Alpha 1 - antitrypsin deficiency: diagnosis and treatment
Source: Virtual Congress 2021 – Alpha 1 - antitrypsin deficiency: diagnosis and treatment
Year: 2021
Alpha 1-antitrypsin deficiency
Source: Breathe 2008; 4: 377-380
Year: 2008
A case report of alpha 1-antitrypsin deficiency in a six-month infant
Source: Eur Respir J 2004; 24: Suppl. 48, 228s
Year: 2004
Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Long-term experience in the treatment of alpha 1-antitrypsin deficiency: 25 years of augmentation therapy
Source: Eur Respir Rev 2015; 24: 46-51
Year: 2015
Expanding the awareness of Alpha-1 antitrypsin deficiency (AATD) to provide a multidisciplinary approach to care
Source: Virtual Congress 2020 – Airway diseases
Year: 2020
Has cardiopulmonary exercise testing a role in detecting early emphysema in alpha 1-antitrypsin deficiency?
Source: Eur Respir J 2001; 18: Suppl. 33, 84s
Year: 2001
Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
Implementation of screening program for alpha-1 antitrypsin deficiency in Spain
Source: Annual Congress 2004 - Emphysema and oxygen therapy
Year: 2004
The patient perspective of alpha-1 antitrypsin deficiency: disease burden and unmet needs
Source: Breathe, 17 (1) 200340; 10.1183/20734735.0340-2020
Year: 2021
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits
Source: Eur Respir J, 50 (3) 1700198; 10.1183/13993003.00198-2017
Year: 2017
Decline in health status in alpha1 antitrypsin deficiency
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017
Diagnosis of alpha 1 antitrypsin deficiency in primary care
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Alpha-1 antitrypsin deficiency severity and the risk of COVID-19
Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19
Year: 2021
Clinical and functional characteristics of Italian and Spanish patients with alpha 1-antitrypsin deficiency
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept